American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Adobe’s (ADBE) “Market Perform” Rating Reiterated at JMP Securities

Adobe’s (ADBE) “Market Perform” Rating Reiterated at JMP Securities

JMP Securities restated their market perform rating on shares of Adobe (NASDAQ:ADBE – Free Report) in a report published on Thursday morning, Benzinga reports. ADBE has been the subject of several other research reports. BMO... More of this article »
Image about Abrdn Healthcare Investors (NYSE:HQH) Shares Pass Below 50-Day Moving Average of $17.02

Abrdn Healthcare Investors (NYSE:HQH) Shares Pass Below 50-Day Moving Average of $17.02

Abrdn Healthcare Investors (NYSE:HQH – Get Free Report)’s share price crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $17.02 and traded as low as $16.83. Abrdn... More of this article »
Image about Redx Pharma (LON:REDX) Share Price Crosses Below 50 Day Moving Average of $19.91

Redx Pharma (LON:REDX) Share Price Crosses Below 50 Day Moving Average of $19.91

Shares of Redx Pharma Plc (LON:REDX – Get Free Report) crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 19.91 ($0.25) and traded as low as GBX 18 ($0.23). Redx... More of this article »
Image about Evercore ISI Boosts Zions Bancorporation, National Association (NASDAQ:ZION) Price Target to $48.00

Evercore ISI Boosts Zions Bancorporation, National Association (NASDAQ:ZION) Price Target to $48.00

Zions Bancorporation, National Association (NASDAQ:ZION – Free Report) had its price target hoisted by Evercore ISI from $47.00 to $48.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently... More of this article »
Image about Weibo (NASDAQ:WB) Given Neutral Rating at The Goldman Sachs Group

Weibo (NASDAQ:WB) Given Neutral Rating at The Goldman Sachs Group

The Goldman Sachs Group reissued their neutral rating on shares of Weibo (NASDAQ:WB – Free Report) in a research note issued to investors on Thursday, MarketBeat Ratings reports. The brokerage currently has a $10.60 price target... More of this article »
Image about China Coal Energy (OTCMKTS:CCOZY) Share Price Crosses Below 50 Day Moving Average of $20.29

China Coal Energy (OTCMKTS:CCOZY) Share Price Crosses Below 50 Day Moving Average of $20.29

China Coal Energy Company Limited (OTCMKTS:CCOZY – Get Free Report)’s share price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $20.29 and traded as low... More of this article »
Image about Romios Gold Resources (CVE:RG) Trading 50% Higher

Romios Gold Resources (CVE:RG) Trading 50% Higher

Romios Gold Resources Inc. (CVE:RG – Get Free Report) traded up 50% during mid-day trading on Friday . The stock traded as high as C$0.02 and last traded at C$0.02. 144,504 shares traded hands during mid-day trading, a decline... More of this article »
Image about HC Wainwright Reiterates Buy Rating for Acrivon Therapeutics (NASDAQ:ACRV)

HC Wainwright Reiterates Buy Rating for Acrivon Therapeutics (NASDAQ:ACRV)

HC Wainwright reissued their buy rating on shares of Acrivon Therapeutics (NASDAQ:ACRV – Free Report) in a research report released on Thursday, Benzinga reports. HC Wainwright currently has a $20.00 price target on the stock. Separately,... More of this article »
Image about Tilly’s (NYSE:TLYS) Stock Passes Below 50-Day Moving Average of $7.29

Tilly’s (NYSE:TLYS) Stock Passes Below 50-Day Moving Average of $7.29

Tilly’s, Inc. (NYSE:TLYS – Get Free Report) shares crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $7.29 and traded as low as $6.79. Tilly’s shares... More of this article »
Image about Annexon (NASDAQ:ANNX) Price Target Increased to $10.00 by Analysts at Bank of America

Annexon (NASDAQ:ANNX) Price Target Increased to $10.00 by Analysts at Bank of America

Annexon (NASDAQ:ANNX – Free Report) had its target price increased by Bank of America from $7.00 to $10.00 in a research note published on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. A... More of this article »
Image about European Opportunities Trust (LON:JEO) Stock Crosses Below 50-Day Moving Average of $843.00

European Opportunities Trust (LON:JEO) Stock Crosses Below 50-Day Moving Average of $843.00

European Opportunities Trust plc (LON:JEO – Get Free Report)’s share price passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 843 ($10.65) and traded as low... More of this article »
Image about Adobe (NASDAQ:ADBE) Rating Reiterated by DA Davidson

Adobe (NASDAQ:ADBE) Rating Reiterated by DA Davidson

DA Davidson reaffirmed their buy rating on shares of Adobe (NASDAQ:ADBE – Free Report) in a research note published on Thursday, Benzinga reports. DA Davidson currently has a $685.00 price objective on the software company’s... More of this article »
Image about Rainbow Rare Earths (LON:RBW) Receives Buy Rating from Berenberg Bank

Rainbow Rare Earths (LON:RBW) Receives Buy Rating from Berenberg Bank

Berenberg Bank reaffirmed their buy rating on shares of Rainbow Rare Earths (LON:RBW – Free Report) in a research report sent to investors on Thursday morning, MarketBeat reports. Berenberg Bank currently has a GBX 38 ($0.48)... More of this article »
Image about Amgen (NASDAQ:AMGN) Coverage Initiated by Analysts at Raymond James

Amgen (NASDAQ:AMGN) Coverage Initiated by Analysts at Raymond James

Raymond James assumed coverage on shares of Amgen (NASDAQ:AMGN – Free Report) in a report released on Thursday morning, MarketBeat.com reports. The firm issued a market perform rating on the medical research company’s stock. AMGN... More of this article »
Image about Xeris Biopharma (NASDAQ:XERS) Coverage Initiated by Analysts at Oppenheimer

Xeris Biopharma (NASDAQ:XERS) Coverage Initiated by Analysts at Oppenheimer

Oppenheimer began coverage on shares of Xeris Biopharma (NASDAQ:XERS – Free Report) in a report issued on Thursday morning, MarketBeat reports. The brokerage issued an outperform rating and a $5.00 target price on the stock. Separately,... More of this article »